GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM5111
Query DataSets for GSM5111
Status
Public on Jun 25, 2003
Title
Halothane 5 exposures-1
Sample type
RNA
Source name
whole brain
Organism
Rattus norvegicus
Extracted molecule
total RNA
Description
Two 90 minute exposures (3 hr recovery in between) to 0.8% halothane every day for 2.5 days, for a total of 5 exposures
Keywords = Eckenhoff, anesthetics
Submission date
Mar 25, 2003
Last update date
May 27, 2005
Contact name
Roderic Eckenhoff
E-mail(s)
[email protected]
Phone
215-662-3705
Organization name
University of Pennsylvania
Department
Street address
City
Philadelphia
State/province
PA
ZIP/Postal code
19104
Country
USA
Platform ID
GPL85
Series (3)
GSE357
Halothane Repetitive Exposure
GSE752
Halothane/Isoflurane Repetitive Exposures
GSE6433
Halothane/Isoflurane repetitive exposures
Data table header descriptions
ID_REF
VALUE
Affy MAS5.0 Signal
ABS_CALL
Affy MAS5.0 Detection call
QUALITY
Affy MAS5.0 Detection p-value
Data table
ID_REF
VALUE
ABS_CALL
QUALITY
AFFX-MurIL2_at
7
A
0.699394
AFFX-MurIL10_at
5.4
A
0.574038
AFFX-MurIL4_at
2.9
A
0.60308
AFFX-MurFAS_at
3.9
A
0.52976
AFFX-BioB-5_at
89.7
A
0.300606
AFFX-BioB-M_at
76.7
P
0.026111
AFFX-BioB-3_at
28
A
0.195266
AFFX-BioC-5_at
215.7
P
0.001248
AFFX-BioC-3_at
122.8
P
0.030976
AFFX-BioDn-5_at
174.6
P
0.002556
AFFX-BioDn-3_at
1546.3
P
0.000509
AFFX-CreX-5_at
1868.1
P
0.000044
AFFX-CreX-3_at
3188.6
P
0.000044
AFFX-BioB-5_st
32.1
A
0.216524
AFFX-BioB-M_st
44.1
A
0.574038
AFFX-BioB-3_st
12.1
A
0.921998
AFFX-BioC-5_st
8.3
A
0.957038
AFFX-BioC-3_st
5.8
A
0.834139
AFFX-BioDn-5_st
13.7
A
0.48511
AFFX-BioDn-3_st
35.9
A
0.300606
Total number of rows:
8799
Table truncated, full table size
250 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|